All In MedTech

FDA Clearance Tracker · P820088-S017

BSD-500 HYPERTHERMIA SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 20, 2004 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 20, 2004

Approved

Time to decision

116 days

Received Sep 26, 2003. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P820088-S017
Device name
BSD-500 HYPERTHERMIA SYSTEM
Applicant location
Salt Lake City, UT
Received
Sep 26, 2003
Decided
Jan 20, 2004
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P820088

Device type

Device class
Class III

Every decision under product code LOC

FDA's approval statement

As written in FDA's record.

APPROVAL TO REPLACE THE GENERATOR APPROVED IN PMA P820088/S005. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE SAME TRADE NAME, BSD-500 HYPERTHERMIA SYSTEM AND IS INDICATED FOR TREATMENT OF SOLID MALIGNANT TUMORS BY LOCALIZED HEAT DELIVERY.

Source documents

Other decisions for Pyrexar Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.